From the last month, the top ten most viewed oncology articles on Trip:
- Screening for breast cancer with mammography. Cochrane
- Interventions for the treatment of oral and oropharyngeal cancers: targeted therapy and immunotherapy. Cochrane
- A systematic review and economic evaluation of intraoperative tests [RD-100i one-step nucleic acid amplification (OSNA) system and Metasin test] for detecting sentinel lymph node metastases in breast cancer. NIHR HTA
- Aspirin use for the primary prevention of cardiovascular disease and colorectal cancer: U.S. Preventive Services Task Force recommendation statement
- Multiple myeloma. BMJ Best Practice
- Guideline Summary: Oncology evidence-based nutrition practice guideline. Academy of Nutrition and Dietetics
- Parental decision making about the HPV vaccine. Cancer Epidemiology & Biomarkers and Prevention
- Immunotherapy for advanced renal cell cancer. Cochrane
- Cancer and Rehabilitation (Treatment). eMedicine
- Cervical cancer and HPV. NICE CKS
Two stand out articles in the list for me – 7 and 9. All the other articles are ‘secondary evidence’.
In the case of 7 it’s a primary research article and it’s from 2010. So, as well as being primary research, it’s also relatively old. This is significant as it potentially links in with our efforts to gather uncertainties (to improve research procurement – both primary and secondary research). We’re always looking to analyse click patterns to see if we can unearth uncertainties but finding the rights signals is problematic. The fact that a significant number of users have an information need met by an oldish article from down the evidence pyramid suggests it’s a ‘hot topic’. Perhaps one for a systematic review or further research?
Number 9 is an eTextbook – the lowest level of evidence (in the Trip hierarchy). Again, lots of interest and users are not finding their information need met by higher quality research.
I’m excited by this ‘discovery’ one to discuss with my research funding colleagues!